Hospitals Decry Genentech's Cancer Drug Delivery Overhaul
Six hospital associations called on Genentech Inc. on Monday to nix its decision to solely promulgate three cancer drugs via specialty distributors rather than traditional wholesale providers, saying the "misguided" plan...To view the full article, register now.
Already a subscriber? Click here to view full article